Why the study?
Is the Per3 VNTR polymorphism associated with the risk or severity of chronic heart failure?
Is the Per3 VNTR polymorphism associated with the risk or severity of chronic heart failure?
The Per3 VNTR polymorphism does not appear to be a major risk factor for the development or severity of chronic heart failure in Caucasian populations.
Answers are grounded in this paper and cite their sources.
No association seen in this case-control study; leaves open Per3 VNTR role in CHF risk or severity.
AIMS: The aim of this study was to investigate the relationship between gene Period3 (Per3) variable number tandem repeat (VNTR) polymorphism and chronic heart failure (CHF). METHODS: The study subjects (372 patients of Caucasian origin with CHF and 332 healthy controls) were genotyped for Per3 VNTR polymorphism using an allele-specific PCR. RESULTS: No significant differences in genotype or Per3 VNTR allele frequencies were found between CHF cases and controls (Pg=0.30, Pa=0.52). No significant differences were uncovered either between CHF cases according to etiology (DCMP vs. IHD; Pg=0.87, Pa=0.91). In the multivariate regression modeling, no predictive function of VNTR Per3 polymorphism on ejection fraction or NYHA class, hyperlipidaemia or type II diabetes risk was found. CONCLUSION: Per3 VNTR polymorphism is not a major risk factor for chronic heart failure or a factor modulating the severity of the CHF in this population.
No takes yet. Share an insight, caveat, or question.
Lipková et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: